Global Helminthic Infestations Therapeutics Market Research Report 2019
Table of Contents
Executive Summary
1 Helminthic Infestations Therapeutics Market Overview
- 1.1 Product Overview and Scope of Helminthic Infestations Therapeutics
- 1.2 Helminthic Infestations Therapeutics Segment by Type
- 1.2.1 Global Helminthic Infestations Therapeutics Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Benzimidazole
- 1.2.3 Pyrantel
- 1.2.4 Piperazine Citrate
- 1.2.5 Others
- 1.3 Helminthic Infestations Therapeutics Segment by Application
- 1.3.1 Helminthic Infestations Therapeutics Consumption Comparison by Application (2014-2025)
- 1.3.2 Enterobius vermicularis
- 1.3.3 Taenia saginata
- 1.3.4 Ascaris lumbricoides
- 1.3.5 Trichuris trichiura
- 1.3.6 Others
- 1.3 Global Helminthic Infestations Therapeutics Market by Region
- 1.3.1 Global Helminthic Infestations Therapeutics Market Size Region
- 1.3.2 North America Status and Prospect (2014-2025)
- 1.3.3 Europe Status and Prospect (2014-2025)
- 1.3.4 China Status and Prospect (2014-2025)
- 1.3.5 Japan Status and Prospect (2014-2025)
- 1.3.6 Southeast Asia Status and Prospect (2014-2025)
- 1.3.7 India Status and Prospect (2014-2025)
- 1.4 Global Helminthic Infestations Therapeutics Market Size
- 1.4.1 Global Helminthic Infestations Therapeutics Revenue (2014-2025)
- 1.4.2 Global Helminthic Infestations Therapeutics Production (2014-2025)
2 Global Helminthic Infestations Therapeutics Market Competition by Manufacturers
- 2.1 Global Helminthic Infestations Therapeutics Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Helminthic Infestations Therapeutics Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Helminthic Infestations Therapeutics Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Helminthic Infestations Therapeutics Production Sites, Area Served, Product Types
- 2.5 Helminthic Infestations Therapeutics Market Competitive Situation and Trends
- 2.5.1 Helminthic Infestations Therapeutics Market Concentration Rate
- 2.5.2 Helminthic Infestations Therapeutics Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Helminthic Infestations Therapeutics Production Market Share by Regions
- 3.1 Global Helminthic Infestations Therapeutics Production Market Share by Regions
- 3.2 Global Helminthic Infestations Therapeutics Revenue Market Share by Regions (2014-2019)
- 3.3 Global Helminthic Infestations Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Helminthic Infestations Therapeutics Production
- 3.4.1 North America Helminthic Infestations Therapeutics Production Growth Rate (2014-2019)
- 3.4.2 North America Helminthic Infestations Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Helminthic Infestations Therapeutics Production
- 3.5.1 Europe Helminthic Infestations Therapeutics Production Growth Rate (2014-2019)
- 3.5.2 Europe Helminthic Infestations Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Helminthic Infestations Therapeutics Production (2014-2019)
- 3.6.1 China Helminthic Infestations Therapeutics Production Growth Rate (2014-2019)
- 3.6.2 China Helminthic Infestations Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Helminthic Infestations Therapeutics Production (2014-2019)
- 3.7.1 Japan Helminthic Infestations Therapeutics Production Growth Rate (2014-2019)
- 3.7.2 Japan Helminthic Infestations Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Helminthic Infestations Therapeutics Consumption by Regions
- 4.1 Global Helminthic Infestations Therapeutics Consumption by Regions
- 4.2 North America Helminthic Infestations Therapeutics Consumption (2014-2019)
- 4.3 Europe Helminthic Infestations Therapeutics Consumption (2014-2019)
- 4.4 China Helminthic Infestations Therapeutics Consumption (2014-2019)
- 4.5 Japan Helminthic Infestations Therapeutics Consumption (2014-2019)
5 Global Helminthic Infestations Therapeutics Production, Revenue, Price Trend by Type
- 5.1 Global Helminthic Infestations Therapeutics Production Market Share by Type (2014-2019)
- 5.2 Global Helminthic Infestations Therapeutics Revenue Market Share by Type (2014-2019)
- 5.3 Global Helminthic Infestations Therapeutics Price by Type (2014-2019)
- 5.4 Global Helminthic Infestations Therapeutics Production Growth by Type (2014-2019)
6 Global Helminthic Infestations Therapeutics Market Analysis by Applications
- 6.1 Global Helminthic Infestations Therapeutics Consumption Market Share by Application (2014-2019)
- 6.2 Global Helminthic Infestations Therapeutics Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Helminthic Infestations Therapeutics Business
- 7.1 Neural Analytics, Inc.
- 7.1.1 Neural Analytics, Inc. Helminthic Infestations Therapeutics Production Sites and Area Served
- 7.1.2 Helminthic Infestations Therapeutics Product Introduction, Application and Specification
- 7.1.3 Neural Analytics, Inc. Helminthic Infestations Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 M3 Biotechnology, Inc.
- 7.2.1 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Production Sites and Area Served
- 7.2.2 Helminthic Infestations Therapeutics Product Introduction, Application and Specification
- 7.2.3 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Cerevance
- 7.3.1 Cerevance Helminthic Infestations Therapeutics Production Sites and Area Served
- 7.3.2 Helminthic Infestations Therapeutics Product Introduction, Application and Specification
- 7.3.3 Cerevance Helminthic Infestations Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Mitochon Pharmaceuticals, Inc.
- 7.4.1 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Production Sites and Area Served
- 7.4.2 Helminthic Infestations Therapeutics Product Introduction, Application and Specification
- 7.4.3 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Peptilogics
- 7.5.1 Peptilogics Helminthic Infestations Therapeutics Production Sites and Area Served
- 7.5.2 Helminthic Infestations Therapeutics Product Introduction, Application and Specification
- 7.5.3 Peptilogics Helminthic Infestations Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Farmoquimica S/A
- 7.6.1 Farmoquimica S/A Helminthic Infestations Therapeutics Production Sites and Area Served
- 7.6.2 Helminthic Infestations Therapeutics Product Introduction, Application and Specification
- 7.6.3 Farmoquimica S/A Helminthic Infestations Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 biOasis Technologies, Inc.
- 7.7.1 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Production Sites and Area Served
- 7.7.2 Helminthic Infestations Therapeutics Product Introduction, Application and Specification
- 7.7.3 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 HCA Healthcare, Inc.
- 7.8.1 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Production Sites and Area Served
- 7.8.2 Helminthic Infestations Therapeutics Product Introduction, Application and Specification
- 7.8.3 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Alzeca Biosciences, Inc.
- 7.9.1 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Production Sites and Area Served
- 7.9.2 Helminthic Infestations Therapeutics Product Introduction, Application and Specification
- 7.9.3 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Johnson & Johnson
- 7.10.1 Johnson & Johnson Helminthic Infestations Therapeutics Production Sites and Area Served
- 7.10.2 Helminthic Infestations Therapeutics Product Introduction, Application and Specification
- 7.10.3 Johnson & Johnson Helminthic Infestations Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
8 Helminthic Infestations Therapeutics Manufacturing Cost Analysis
- 8.1 Helminthic Infestations Therapeutics Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Helminthic Infestations Therapeutics
- 8.4 Helminthic Infestations Therapeutics Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Helminthic Infestations Therapeutics Distributors List
- 9.3 Helminthic Infestations Therapeutics Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Helminthic Infestations Therapeutics Market Forecast
- 11.1 Global Helminthic Infestations Therapeutics Production, Revenue Forecast
- 11.1.1 Global Helminthic Infestations Therapeutics Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Helminthic Infestations Therapeutics Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Helminthic Infestations Therapeutics Price and Trend Forecast (2019-2025)
- 11.2 Global Helminthic Infestations Therapeutics Production Forecast by Regions (2019-2025)
- 11.2.1 North America Helminthic Infestations Therapeutics Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Helminthic Infestations Therapeutics Production, Revenue Forecast (2019-2025)
- 11.2.3 China Helminthic Infestations Therapeutics Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Helminthic Infestations Therapeutics Production, Revenue Forecast (2019-2025)
- 11.3 Global Helminthic Infestations Therapeutics Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Helminthic Infestations Therapeutics Consumption Forecast (2019-2025)
- 11.3.2 Europe Helminthic Infestations Therapeutics Consumption Forecast (2019-2025)
- 11.3.3 China Helminthic Infestations Therapeutics Consumption Forecast (2019-2025)
- 11.3.4 Japan Helminthic Infestations Therapeutics Consumption Forecast (2019-2025)
- 11.4 Global Helminthic Infestations Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Helminthic Infestations Therapeutics Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
The global Helminthic Infestations Therapeutics market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Helminthic Infestations Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Helminthic Infestations Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Neural Analytics, Inc.
M3 Biotechnology, Inc.
Cerevance
Mitochon Pharmaceuticals, Inc.
Peptilogics
Farmoquimica S/A
biOasis Technologies, Inc.
HCA Healthcare, Inc.
Alzeca Biosciences, Inc.
Johnson & Johnson
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Benzimidazole
Pyrantel
Piperazine Citrate
Others
Segment by Application
Enterobius vermicularis
Taenia saginata
Ascaris lumbricoides
Trichuris trichiura
Others